MedTrace Logo

Parabiotics Use with Nutritional Management in Pediatric Celiac Patients

NCT06870643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-03-19

No results posted yet for this study

Summary

This is a sequential study to evaluate the effect of parabiotics as an adjuvant therapy with gluten restriction on quality of life in children with Celiac disease.

Conditions

  • Celiac Disease in Children

Interventions

OTHER

Gluten free diet for 3 weeks then parabiotic (Lacteolfort®) for another 3 weeks

Gluten free diet for 3 weeks then parabiotic (Lacteolfort®) for another 3 weeks.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-12
Primary Completion
2024-12-26
Completion
2025-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06870643 on ClinicalTrials.gov